Literature DB >> 24913086

Acute renal failure and type B lactic acidosis as first manifestation of extranodal T-cell lymphoblastic lymphoma.

Seongseok Yun1, Courtney N Walker1, Nicole D Vincelette2, Faiz Anwer1.   

Abstract

We describe a rare case of a 19-year-old male patient with a history of epilepsy and developmental delay who presented with acute renal failure (ARF) and lactic acidosis (LA) as the first manifestation of T-cell lymphoblastic lymphoma. Renal ultrasound and CT of the abdomen showed renal parenchymal infiltration, and renal biopsy demonstrated T-cell lymphoblastic lymphoma. LA, ARF and electrolyte abnormalities were refractory to the initial treatment of bicarbonate infusion and hydration. However, these abnormalities rapidly normalised after the initiation of chemotherapy, suggesting that the LA and ARF were secondary to lymphomatous renal infiltration. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 24913086      PMCID: PMC4054106          DOI: 10.1136/bcr-2014-205044

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  34 in total

Review 1.  Type B lactic acidosis as a severe metabolic complication in lymphoma and leukemia: a case series from a single institution and literature review.

Authors:  Allison S Friedenberg; Douglas E Brandoff; Fred J Schiffman
Journal:  Medicine (Baltimore)       Date:  2007-07       Impact factor: 1.889

2.  Tumor lysis syndrome: current perspective.

Authors:  Jessica Hochberg; Mitchell S Cairo
Journal:  Haematologica       Date:  2008-01       Impact factor: 9.941

3.  Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation.

Authors:  P Corradini; C Tarella; F Zallio; A Dodero; M Zanni; P Valagussa; A M Gianni; A Rambaldi; T Barbui; S Cortelazzo
Journal:  Leukemia       Date:  2006-07-27       Impact factor: 11.528

4.  Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement.

Authors:  P Lin; D Jones; D M Dorfman; L J Medeiros
Journal:  Am J Surg Pathol       Date:  2000-11       Impact factor: 6.394

Review 5.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

Review 6.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Authors:  James W Vardiman; Jüergen Thiele; Daniel A Arber; Richard D Brunning; Michael J Borowitz; Anna Porwit; Nancy Lee Harris; Michelle M Le Beau; Eva Hellström-Lindberg; Ayalew Tefferi; Clara D Bloomfield
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113

7.  Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model.

Authors:  Pau Montesinos; Ignacio Lorenzo; Guillermo Martín; Jaime Sanz; Maria Luz Pérez-Sirvent; David Martínez; Guillermo Ortí; Lorenzo Algarra; Jesus Martínez; Federico Moscardó; Javier de la Rubia; Isidro Jarque; Guillermo Sanz; Miguel A Sanz
Journal:  Haematologica       Date:  2008-01       Impact factor: 9.941

Review 8.  Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review.

Authors:  Bertrand Coiffier; Arnold Altman; Ching-Hon Pui; Anas Younes; Mitchell S Cairo
Journal:  J Clin Oncol       Date:  2008-06-01       Impact factor: 44.544

9.  Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.

Authors:  Michael Pfreundschuh; Lorenz Trümper; Marita Kloess; Rudolf Schmits; Alfred C Feller; Christian Rübe; Christian Rudolph; Marcel Reiser; Dieter K Hossfeld; Hartmut Eimermacher; Dirk Hasenclever; Norbert Schmitz; Markus Loeffler
Journal:  Blood       Date:  2004-03-11       Impact factor: 22.113

10.  Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B-NHL: a Children's Oncology Group Report.

Authors:  Paul J Galardy; Jessica Hochberg; Sherrie L Perkins; Lauren Harrison; Stanton Goldman; Mitchell S Cairo
Journal:  Br J Haematol       Date:  2013-09-06       Impact factor: 6.998

View more
  2 in total

1.  Type B lactic acidosis: a rare but life threatening hematologic emergency. A case illustration and brief review.

Authors:  Wederson M Claudino; Ajoy Dias; William Tse; Vivek R Sharma
Journal:  Am J Blood Res       Date:  2015-06-15

Review 2.  A case of type B lactic acidosis as a complication of chronic myelomonocytic leukaemia: a case report and review of the literature.

Authors:  Andrew John Gardner; John Griffiths
Journal:  J Med Case Rep       Date:  2015-01-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.